Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment

QR Code

Effects of metformin on body weight in patients with type 2 diabetes mellitus,receiving insulin analogue treatment

Aims. To study the dynamics of body weight, waist circumference, blood lipid and insulin demand in patients with type 2 diabetes mellitus (T2DM) during first year of combined treatment with metformin and insulin analogues, compared with insulin analogue monotherapy. Materials and Methods. We exami...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tatiana Ivanovna Romantsova, T Sh Dzhavakhishvili, O V Roik
Format:	article
Langue:	EN RU
Publié:	Endocrinology Research Centre 2013
Sujets:	diabetes mellitus type 2 insulin therapy insulin analogues metformin Nutritional diseases. Deficiency diseases RC620-627
Accès en ligne:	https://doaj.org/article/036d8227a68a44eca926ab8e0dc1657b
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Individual stepwise intensification of insulin analogue therapy in type 2 diabetes mellitus
par: Alexander Sergeevich Ametov, et autres
Publié: (2012)

Modern approach to the evaluation of the pharmacokinetics and pharmacodynamics of biosimilar recombinant human insulin and insulin analogues in I phase clinical study
par: Irina A. Proskurina, et autres
Publié: (2016)

Insulin degludec: a new basal insulin analogue with an ultra-long duration of action. Safety and efficacy in Russian patients with diabetes
par: Marina Vladimirovna Shestakova, et autres
Publié: (2015)

Pharmacoeconomic analysis of clinical efficiency of combined metformin (Siofor) - insulin therapy in patients with type 2 diabetes mellitus
par: I Yu Demidova, et autres
Publié: (2009)

On the centenary of the insulin discovery
par: I. I. Dedov, et autres
Publié: (2021)

Comparative analysis of glycemic control effectiveness and microvascular complications in patients with type 1 diabetes mellitus, treated with genetically engineered human insulin or human insulin analogues: A 10-year retrospective observational study
par: Marina V. Shestakova, et autres
Publié: (2016)

Lypohypertrophy in patients receiving insulin therapy: state of the art
par: Natalya Ivanovna Volkova, et autres
Publié: (2011)

A1chieve Program in Russian Federation: a multicenter prospective observational study of insulin analogue treatment efficiency and safety in daily management of patients with type 2 diabetes mellitus, who startand intensify insulin treatment having never received it before
par: Marina Vladimirovna Shestakova
Publié: (2012)

Modern basal insulins: an ongoing story or the start of a new era?
par: Ivan Ivanovich Dedov
Publié: (2015)

The first and only combination of basal and prandial insulin analogs degludec and aspart: the position of Russian endocrinologists
par: M. V. Shestakova, et autres
Publié: (2021)

Modern approach to basal-bolus therapy with glargine and glulisine insulin analoguesin various age groups
par: Natalya Nikitichna Volevodz, et autres
Publié: (2013)

Comparative efficacy assessment for various insulin regimens in patients with type 2 diabetes mellitus, ischaemic heart disease and frequent hypoglycemic events
par: Vladimir Ivanovich Kudinov, et autres
Publié: (2012)

Optimization of therapy of type 2 diabetes mellitus with the oral hypoglycemic agent glimepiride
par: Tatiana Ivanovna Romantsova, et autres
Publié: (2010)

Insulin therapy and body weight: benefits of biphasic human insulin analogue NovoMix 30
par: Elena Viktorovna Surkova
Publié: (2013)

Insulin degludec/insulin aspart is the first co-formulation of basal and prandial insulin analogues
par: Ivan Ivanovich Dedov, et autres
Publié: (2014)

Efficacy and safety of treatment with human insulin analogues in daily management of insulin naive patients with type 2 diabetes mellitus: results of multicenter 52-week observational study A1chive
par: Marina Vladimirovna Shestakova
Publié: (2012)

Hormonal, metabolic and genetic predictors of metformin efficacy in patients with diabetes mellitus and cancer
par: Lev Mikhaylovich Bershteyn, et autres
Publié: (2014)

Statin use and risk of diabetes mellitus
par: Oksana Mikhailovna Drapkina, et autres
Publié: (2012)

Overcoming marked insulin resistance in a patient with type 2 diabetes mellitus by means of insulin pumptherapy
par: Ekaterina Viktorovna Artemova, et autres
Publié: (2012)

Clinical and economic analysis of the modern strategies for treating metabolic syndrome
par: Marina Fedorovna Kalashnikova, et autres
Publié: (2014)

Risk of oncological diseases in patients with diabetes mellitus
par: Gagik Radikovich Galstyan
Publié: (2009)

When basal insulin is not enough: successful strategies for insulin intensification in patients with type 2 diabetes mellitus
par: Elena V. Buryukova, et autres
Publié: (2017)

Insulin degludec is a new ultra-long-acting insulin analogue
par: Ivan Ivanovich Dedov, et autres
Publié: (2014)

Modern antihyperglycemic agents prescribed in Russia for type 2 diabetes mellitus
par: Yury Ivanovich Suntsov
Publié: (2012)

Insulin-induced lipohypertrophy: clinical and ultrasound characteristics
par: Vadim V. Klimontov, et autres
Publié: (2018)

Effective and safe control of glycemia with insulin Apidra - the recipe for success of type 2 diabetes prophylaxis
par: Elena Valer'evna Biryukova
Publié: (2011)

One-hour postload plasma glucose levels as a new criterion for assessing insulin secretion in obese children
par: O. V. Vasyukova, et autres
Publié: (2021)

Dose adjustment in insulin pump therapy: optimization of bolus calculator settings
par: Yury Ivanovich Filippov, et autres
Publié: (2012)

Metformin regulates glycemic homeostasis in patients with type 2 diabetes mellitus as an NO donor
par: Ivan Sergeevich Kuznetsov, et autres
Publié: (2013)

The role of insulin analogs in the achievement of compensation and improvement of quality of life in children and adolescents with type 1 diabetes mellitus
par: Tamara Leonidovna Kuraeva
Publié: (2010)

Basal insulin therapy in patients with type 2 diabetes mellitus and poor control of glycemia by oral hypoglycemic agents: results of direct comparative study of insulin analogs Lantus and Levemir
par: Alsu Gafurovna Zalevskaya, et autres
Publié: (2010)

Lantus, the first peakless basal insulin analogue: 10 years of clinical experience in children and adolescents
par: Tamara Leonidovna Kuraeva
Publié: (2014)

Functional activity and peripheral insulin resistance in patients with different types of onset of diabetes mellitus
par: Tatiana Vasil'evna Nikonova, et autres
Publié: (2012)

Insulin pump therapy of type 1 diabetes mellitus in children and adolescents in the Moscow region
par: Elena Efimovna Petryaykina, et autres
Publié: (2009)

Intraperitoneal insulin infusion: on the way to the artificial pancreas
par: Vladimir Aleksandrovich Karpel'ev, et autres
Publié: (2015)

Birth weight and length in offsprings of mothers with gestational diabetes mellitus due to mutations in GCK gene
par: Natalia A. Zubkova, et autres
Publié: (2018)

Insulin pump therapy in children with diabetes mellitus: practice of Krasnoyarsk Krai
par: Tatiana Evgen'evna Taranushenko, et autres
Publié: (2012)

Metformin and cancer mortality
par: Lev Mikhaylovich Bershteyn
Publié: (2010)

Priority areas in management of diabetes mellitus type 1 & 2 (following 47th EASD Annual Meeting)
par: Ivona Renata Yarek-Martynova, et autres
Publié: (2011)

Quality of glycemic control in assessment of the requirement for insulin in patients with type 2 diabetes and comorbid pathology
par: Irina A. Kurnikova, et autres
Publié: (2018)